Opiate and muscarinic ligand binding in five limbic areas after bilateral olfactory bulbectomy

Bilateral olfactory bulbectomy (BBX) in mice leads to a variety of neurochemical changes in 5 limbic areas associated with the bulbs. Within one week after BBX, opiate ligand binding declined by 73% in the amygdala, rose by 82% in the hypothalamus and then returned to sham levels by 4 weeks in both areas. Opiate binding also declined by 47% in the olfactory tubercle and to essentially zero in the piriform cortex and the olfactory peduncle after 16 weeks. Muscarinic cholinergic binding declined in the amygdala and hypothalamus at 16 weeks after BBX, but reductions in muscarinic binding were observed in the piriform cortex and the olfactory peduncle by two weeks postsurgery. Muscarinic binding in the olfactory tubercle was unaffected by BBX, as was binding of β-adrenergic and benzodiazepine ligands in the limbic areas. Binding of [ 3H]spiroperidol rose 61% in the olfactory tubercle two weeks after surgery and then declined to normal levels. Choline acetyl-transferase activity rose by 64% within one week after BBX in the piriform cortex and remained elevated throughout the study. Activity of this enzyme also rose in the olfactory peduncle and the olfactory tubercle after surgery. BBX had only moderate effects on glutamic acid decar☐ylase in the limbic areas, and enzyme activity increased 25% in the olfactory tubercle and the piriform cortex 4 weeks after BBX. BBX also resulted in a moderate decrease (22%) in DOPA decar☐ylase activity in the olfactory tubercle two weeks after BBX. The implications of these neurochemical changes are discussed in terms of what is known about bulb-limbic system connections.